Delphine Perridy, Chief Commercial Officer at Envirotainer explores six essential predictions shaping pharmaceutical logistics and cold chain for the year ahead.

The pharmaceutical cold chain is becoming a cornerstone of global supply chains, shaped by new regulations, innovation, and the need for resilience.

This year, the industry witnessed remarkable innovations across the broader pharmaceutical distribution landscape. One standout development was the rapid growth of direct-to-patient logistics. Pharmaceutical companies have made strides in delivering treatments directly to patients’ homes. These advancements not only enhance patient access but also reflect a wider trend towards personalised, patient-centric supply chains.

Hard on the heels of a year shaped by innovation, sustainability, and security, 2025 now promises the pharmaceutical industry even greater transformation.

Strengthening Supply Chain Resilience
Over this past year, global tensions and geopolitical conflicts have created ongoing logistical disruptions and bottlenecks. These challenges can vary from port closures to sanctions or trade restrictions, all of which impact delivery efficiency and cost. Such issues expose vulnerabilities in the pharmaceutical supply chain, leading to significant delays or, in worse cases, spoiled or cancelled shipments.